Arbutus to present at jefferies london healthcare conference

Warminster, pa., nov. 08, 2022 (globe newswire) -- arbutus biopharma corporation (nasdaq: abus), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that william collier, arbutus' president and chief executive officer, will present at the jefferies london healthcare conference on wednesday, november 16, 2022, at 11:30 am gmt / 6:30 am edt.
ABUS Ratings Summary
ABUS Quant Ranking